drugset / Trial / NCT01899430

Polycystic Ovary Syndrome and Liraglutide

NCT01899430

Phase 4 Completed 32 enrolled University Medical Centre Ljubljana
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study was to determine whether liraglutide is more effective than metformin in the treatment of obese women with newly diagnosed polycystic ovary syndrome (PCOS). We anticipated greater changes in body weight in patients treated with liraglutide than in those treated with metformin.

Timeline

Start
2011-11
Primary completion
2012-10
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Liraglutide Peptide 1.2 mg Subcutaneous
Comparator Metformin Small molecule 1000 mg Oral